On November 25, Mr.Sranyoo Chanate, CEO of Kluaynamthai Hospital in Thailand, and Mr.Seldon Young, Producer of Swan Princess Partners LLC, visited Shenzhen Cell Valley for an exchange. Our company's Chief Scientist Professor Wang Jianxun, Business Director Wei Zheng, Assistant to the Chairman Dr. Fu Yuchen, and Director of the General Office Wang Lu warmly received them and held a symposium.

Under the introduction of Professor Wang Jianxun, Mr.Sranyoo and his delegation first visited the Shenzhen Cell Valley Smart Exhibition Hall, where they gained an initial understanding of the company's business and capabilities as a one-stop solution provider for cell and gene therapy. Subsequently, they conducted an in-depth tour of the company's production, quality control laboratory, and R&D center, gaining detailed insights into the latest scientific research achievements and technological advancements in the field of cell and gene therapy.

At the symposium, Dr. Fu Yuchen elaborated on the leading advantages and market prospects of Shenzhen Cell Valley in cell therapy technology. Professor Wang Jianxun further emphasized that with the advancement of global medical technology and the heightened awareness of health, the cell therapy market is entering a new era of rapid development, offering broad prospects and immense market potential. Leveraging China's leading GMP-grade industrial production process for retroviral vectors and a comprehensive, one-stop service workflow from basic scientific research to clinical application translation, Shenzhen Cell Valley has established partnerships with nearly 200 domestic and international collaborators. The company has also progressively expanded into the Southeast Asian market, achieving significant breakthroughs in regional markets.

Mr.Sranyoo Chanate is the Chief Executive Officer of Kluaynamthai Hospital in Bangkok, Thailand, and holds a degree from Ngee Ann Polytechnic, a subsidiary of the National University of Singapore. Kluaynamthai Hospital is renowned for its comprehensive medical services, offering treatments across multiple specialized fields including physical therapy, gynecology, orthopedic surgery, psychiatry, and healthcare. As an internationally accredited medical institution, Kluaynamthai Hospital is committed to providing high-quality medical services and demonstrates profound expertise and professional capabilities in various specialized fields. Under the leadership of Mr.Sranyoo Chanate, Kluaynamthai Hospital has become a key provider of medical tourism and local healthcare services in Thailand, thanks to its advanced medical facilities, high-standard services, and meticulous patient care. Mr.Sranyoo Chanate's visit to Shenzhen Cell Valley aims to gain a deeper understanding of the technology and industry there, and he looks forward to establishing long-term and stable cooperative relationships with Shenzhen Cell Valley and future cell therapy industry projects in Thailand.

Subsequently, both parties discussed potential areas and models for future collaboration. This symposium laid a solid foundation for future cooperation between the two sides, marking a significant step forward in their collaboration in the field of cell and gene therapy technologies.